XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422LAA5. A total of 7 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $21,409,596 | +23.4% | 18,000,000 | 0.0% | 0.46% | +18.1% |
| Q1 2023 | $17,348,832 | +1.5% | 18,000,000 | 0.0% | 0.39% | +9.3% |
| Q4 2022 | $17,094,600 | -1.7% | 18,000,000 | 0.0% | 0.35% | +2.3% |
| Q3 2022 | $17,384,000 | -1.3% | 18,000,000 | 0.0% | 0.35% | -4.7% |
| Q2 2022 | $17,607,000 | -16.5% | 18,000,000 | 0.0% | 0.36% | -23.1% |
| Q1 2022 | $21,095,000 | -2.2% | 18,000,000 | 0.0% | 0.47% | +4.2% |
| Q4 2021 | $21,577,000 | +14.4% | 18,000,000 | 0.0% | 0.45% | +23.1% |
| Q3 2021 | $18,864,000 | -33.9% | 18,000,000 | 0.0% | 0.37% | -27.4% |
| Q2 2021 | $28,545,000 | -6.2% | 18,000,000 | 0.0% | 0.51% | -20.7% |
| Q1 2021 | $30,417,000 | -3.9% | 18,000,000 | 0.0% | 0.64% | +2.1% |
| Q4 2020 | $31,658,000 | -12.3% | 18,000,000 | 0.0% | 0.63% | -28.8% |
| Q3 2020 | $36,116,000 | +103.7% | 18,000,000 | 0.0% | 0.88% | +70.3% |
| Q2 2020 | $17,732,000 | – | 18,000,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 7,450,000 | $13,103,000 | 0.84% |
| 683 Capital Management, LLC | 8,100,000 | $14,094,000 | 0.67% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 18,000,000 | $31,658,000 | 0.63% |
| Saltoro Capital, LP | 250,000 | $439,000 | 0.22% |
| UBS OCONNOR LLC | 2,000,000 | $3,461,000,000 | 0.07% |
| LAZARD ASSET MANAGEMENT LLC | 7,875,000 | $13,836,000 | 0.02% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 4,000,000 | $6,948,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |